BioProcess International is a publication that provides insights and information related to the bioprocessing industry. It covers upstream and downstream processing, manufacturing, analytical techniques, and business aspects in biotech.

BioProcess International

Pharma Now is a monthly B2B magazine that covers trends, technological innovations, and insights in the pharmaceutical and biopharmaceutical sectors. It provides industry news and updates, interviews with leaders, market insights, and regulatory updates.

Pharma Now

Biotechnology Research

BioProcess International Academy

BioProcess International | 24,299 followers on LinkedIn. brought to you by Informa Connect | BioProcess International™ is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process. 
BPI is a business unit of Informa Connect https://informaconnect.com

Biologics Analytical CMC and Lab Quality R&D to GMP

Nadine M. Ritter, Ph.D.

Retired

Maribel Rios

TKH Bioconsult LLC

Timothy Hayes

Associate Editor at BioProcess International

Alison Center

That's a wrap on our BioProcess International Conference & Exhibition 2024 in Boston! Aside from our enhanced onsite features including coffee baristas, daily live music, wine & cheese, lobster rolls, masseuse, manicurist, comfort seating, work pods, and charging ports in all session rooms, this year's event featured: ✓ 3200+ bioprocessing professionals from 36 countries ✓ All top 20 largest biopharma companies ✓ 100+ startups ✓ 340+ industry leading speakers across 9 tracks ✓ 220+ exhibitors supporting the entire bioprocessing spectrum ✓ Offsite networking party at Museum of Science Check out the latest highlights from this year's event! #biotechweekboston #BPIevent #CellGeneEvent #bioprocessing

Please join us for a #BPIAskTheExpert on "Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges." Multimodal #chromatography has a history of providing value for #biopharmaceutical separations. Ligands that enable binding based on both charge and #hydrophobic interactions provide more opportunity for effective separation of multiple product- and process-related impurities. However, more diverse protein therapeutics and evolving expression systems present separation challenges that may not be easily addressed by commercially available multimodal resins. This #webinar will discuss several molecules that were prioritized for high-throughput evaluation of Nuvia wPrime 2A Resin, including an IgG1 monoclonal antibody ( #mAb ), IgG4 mAb, and a bispecific antibody ( #bsAb ), with extra focus placed on proteins with low isoelectric points (pI) and known strong binding to alternative MMAEX resins. Date: Thurs., November 14th. Time: 11 AM ET. Featuring: Michael Rauscher , Associate Principal Scientist, Process R&D Enabling Technologies, Merck . Register Now: https://lnkd.in/gsEG7Wjh

Please join us for a #BPIAskTheExpert on "AAE-MS™: A Powerful Method to Assess Host Cell Protein ELISA Fit for Purpose." Antibody Affinity Extraction (AAE) is a powerful orthogonal approach to determine if a host cell protein (HCP) ELISA is fit for purpose. AAE is referenced as immunoaffinity #chromatography in USP 1132 and has been used in over 300 projects to perform antibody coverage analysis for regulatory submissions. This #webinar will focus on several case studies demonstrating utility of AAE-MS method in identification of immunoreactive HCPs to establish HCP antibody coverage, HCPs enriched during process changes, and HCPs co-purified with DS. Date: Tues., November 12th. Time: 11 AM ET. Featuring: Jared Isaac, PhD MBA , Associate Director, Chromatography and Mass Spectrometry, Cygnus Technologies, LLC . Register Now: https://lnkd.in/gZNZEFkX

Please join us for a #BPIAskTheExpert on "Out of the Box Computer Software Assurance with ValGenesis VLMS." Computer software assurance (CSA) allows for faster deployment of your #validation needs compared to traditional computer systems validation (CSV). In this #webinar , learn how you can utilize modern methodologies and digital technologies such as ValGenesis’ VLMS to adapt your current CSV practices into CSA to streamline your validation process. Date: Thurs., November 7th. Time: 11 AM ET. Featuring: Jeff R. , Solutions Engineer, ValGenesis . Register Now: https://lnkd.in/ghsVfBxC

We've had the great opportunity to speak to Eric Halioua , CEO of PDC*line Pharma , on the company’s journey from its inception to its current breakthroughs in cancer immunotherapies. Eric shared insights on the drive behind PDC*line Pharma's unique platform, the resilience required to push forward in biotech, and the impact of global partnerships. Stay tuned for more on how PDC*line Pharma is advancing clinical trials and what we can expect to hear from them at Cell and Gene Therapy International Europe, this December! Read more below: #cellandgenetherapy #biotech #bioprocessing

Please join us for a #BPIAskTheExpert on "Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System." The growing field of #antibody #therapeutics is revolutionizing #healthcare by offering more precise treatments for various diseases. This advancement demands that #pharmaceutical companies efficiently produce high-quality proteins in large volumes. In this webinar, Sanjay Kumar, PhD will discuss Lonza’s CHO media portfolio, with a focus on the TheraPRO® GS CHO media system, highlighting key attributes and sharing compelling data generated with this system. Date: Thurs., October 31st. Time: 11 AM ET. Featuring: Sanjay Kumar , PhD, Head of Technical Excellence, Media Solutions, Lonza Bioscience Media Solutions. Register Now: https://lnkd.in/gACTW4AG

Be sure to check out our latest October 2024 issue of BioProcess International on downstream processing - available in print and digital! This issue features fascinating articles from talented professionals. Read on for a preview of the articles linked below: From the Editor: October 2024 by Cheryl Scott . The Crucial Role of Artificial Intelligence in Enhancing Clinical Outcomes by Ofer Sharon . Overcoming Scalability Barriers To Advance Cell Therapies in Development: CDMOs Can Be the Key to Success by Andy Lewin & Lior Raviv . Next-Generation Laboratory Moves: Strategies To Maximize Your Laboratory-Relocation Plan by Jasmina Xie. Influence of Air-Diffusion Value Shifts on Virus-Clearance Values: Safety Risk Assessment for Virus-Filter Integrity Testing in Multiround Housings HYEJEE JANG , Lalit Saxena , Seonmi Kim, Jihyun Lee , & Yonghwan Jin . Safeguarding Bioproduction Modalities: Comprehensive Testing Strategies Require Reliable Analytical Processes and Reference Materials by Leka Papazisi & Fang Tian . Lessons in Bioreactor Scale-Up, Part 4: Physiochemical Factors Affecting Oxygen Transfer and the Volumetric Mass-Transfer Coefficient in Stirred Tanks by Muhammad Arshad Chaudhry. Single-Use Devices for Alternating Tangential-Flow Filtration: Highly Efficient Perfusion Processes Over 50 Days (Webcast Recap) by Jan Ott . Enabling CDMOs To Focus on Their Core Priorities: Outsourcing Supply-Chain and Buffer-Preparation Activities by César Mauras . Beyond ELISA: Is Mass Spectrometry the Future of Impurity Analysis? by Thomas Kofoed , Margarita Sabater , Bryant McLaughlin , Søren Skov Jensen . Advanced Characterization of HCP Polyclonal Antibodies: Combining Antibody Affinity Extraction and Mass Spectrometry by Alla Zilberman , Jared Isaac, PhD MBA , & Eric Bishop . Fighting Neurodegenerative Diseases: The Need for Combination Biologics by Howard Berman, PhD . #downstreamprocessing #artificialintelligence #celltherapies #supplychain Follow the link below to read the full issue: https://lnkd.in/g4KQh3Xf

Please join us for a #BPIAskTheExpert on "Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency." Poloxamer 188 is a surfactant with a longstanding history of use in #pharmaceutical drugs, spanning dosage routes from oral to topical and parenteral administration. In the #biomanufacturing space, it finds application not only as a surfactant for parenteral biological formulations, but also in #cellculture as a shear stress protectant. Join this #webinar to understand exceptional performance in cell viability performance against competitor materials in both #CHO and #HEK suspension lines, analyze data highlighting batch-to-batch consistency in performance along with supporting #analytical data on the poloxamer compositional and impurity profile. Date: Tues., October 29th. Time: 11 AM ET. Featuring: James Humphrey, Research and Technology Specialist, Garima Sinha Lead Applications Scientist, Jessica Santa Maria, Technical Marketing Lead, Croda Pharma Register Now: https://lnkd.in/giQhCPCP

Please join us tomorrow for a #BPIAskTheExpert on "What if Your Supply Chain forSingle-Use Equipment Was Robust?" The #pandemic should have taught us that dual or multi-sourcing helps to strengthen #supplychains . But did you know that the implications for manufacturers and #CDMOs are even greater? Join this #webinar to learn more about the possibilities of using vendor-independent components for your #biopharmaceutical fluid path. Date: Thurs., October 24th. Time: 11 AM ET. Featuring: David Seifert , Head of Sales Application Engineering Sterile Consumables & Khalil Essani , Product Line Manager, Sterile Consumables, Single Use Support . Register Now: https://lnkd.in/g8YR6T-R

Day 1 of the Bioprocess International Asia Main Conference has officially started! 🥳 Our exceptional chairperson, Daisuke Kajihara , opened the day by introducing our keynote speaker, Takashi Kaminagayoshi from Takeda : 💡 Advanced Biomanufacturing Facilities - A Case Study 💡 We've also heard from Jack Wong and Christiane Hartmann in this morning's first session! Throughout the day, we'll gain valuable insights from a lineup of experts including Niki Wong , Sanjay Nilapwar, Wei Huang, Minh Tran , Jonggu (Kevin) Kim , Changlin Dou, Christoph Herwig , Haruki Takeuchi, Yasuhiro Takagi , Zach Pang, 🌞 Thanks to our sponsors and exhibitors for supporting the event! #BPIAsia #CGT #kyoto #japan #biotech #biopharma Informa Connect Informa Connect Life Sciences BioProcess International

Metric
Company Name	BioProcess International	Pharma Now
Symbol
MSH ID	COM:BIOPROCESSINTL	LIVE:PHARMANOW
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Consumer Services
Industry	Biotechnology	Pharmaceuticals
Country	GB	IN
Stage
Employee Count
Website	bioprocessintl.com	pharmanow.live
LinkedIn	bioprocess-international	pharma-now
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BIOP

COM:BIOPROCESSINTL

BioProcess International

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue